Genome-Wide Association Study of Susceptibility Loci for TCF3-PBX1 Acute Lymphoblastic Leukemia in Children.
Shawn H R LeeMaoxiang QianWentao YangJonathan D DiedrichElizabeth RaetzWenjian YangQian DongMeenakshi DevidasDeqing PeiAllen YeohCheng ChengChing-Hon PuiWilliam E EvansCharles G MullighanStephen P HungerDaniel SavicMary V RellingMignon L LohJun J YangPublished in: Journal of the National Cancer Institute (2022)
Acute lymphoblastic leukemia (ALL) is the most common cancer in children. TCF3-PBX1 fusion defines a common molecular subtype of ALL with unique clinical features, but the molecular basis of its inherited susceptibility is unknown. In a genome-wide association study of 1494 ALL cases and 2057 non-ALL controls, we identified a germline risk locus located in an intergenic region between BCL11A and PAPOLG: rs2665658, P = 1.88 × 10-8 for TCF3-PBX1 ALL vs non-ALL, and P = 1.70 × 10-8 for TCF3-PBX1 ALL vs other-ALL. The lead variant was validated in a replication cohort, and conditional analyses pointed to a single causal variant with subtype-specific effect. The risk variant is located in a regulatory DNA element uniquely activated in ALL cells with the TCF3-PBX1 fusion and may distally modulate the transcription of the adjacent gene REL. Our results expand the understanding of subtype-specific ALL susceptibility and highlight plausible interplay between germline variants and somatic genomic abnormalities in ALL pathogenesis.
Keyphrases
- genome wide association study
- acute lymphoblastic leukemia
- copy number
- young adults
- allogeneic hematopoietic stem cell transplantation
- induced apoptosis
- dna repair
- transcription factor
- genome wide
- single molecule
- gene expression
- squamous cell carcinoma
- oxidative stress
- acute myeloid leukemia
- dna damage
- dna methylation
- circulating tumor